ATXS icon

Astria Therapeutics
ATXS

Overview Fund Trends Analyst Outlook Journalist POV

35 hedge funds and large institutions have $63.8M invested in Astria Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

40% less funds holding

Funds holding: 58 → 35 (-23)

82% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 28

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$262K
Puts
$354K
Net Calls
Net Calls Change

Top Buyers

1
+$6M
2
+$3.7M
3
+$2.39M
4
FFM
Fairmount Funds Management
Pennsylvania
+$2.03M
5
Renaissance Technologies
Renaissance Technologies
New York
+$411K

Top Sellers

1
-$6.73M
2
-$3.75M
3
-$2.48M
4
Millennium Management
Millennium Management
New York
-$974K
5
CAM
Cormorant Asset Management
Massachusetts
-$343K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$28K
27
$27K
28
$11K
29
$3K
30
$1K
31
$1K
32
$1K
33
$1K
34
$1K
35
$1K
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3